Optrahealth patent
WebJul 6, 2024 · About OptraHEALTH: OptraHEALTH is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing a next … WebThe patent is for artificial intelligence technology that automates clinical workflows to return test results and assist physicians in making " real-time, data-driven rich choices that lead …
Optrahealth patent
Did you know?
WebAn end-to-end edge computing. platform that brings the promise. of AI to your business operations. Optra Edge is a first of its kind integrated hardware and software platform. for … WebSan Jose, CA, September 10, 2024: OptraHEALTH ® a leading data-driven intelligence company today announced that the United States Patent and Trademark Office(USPTO) …
WebOptraHEALTH® receives Patent for its conversational AI platform for handling healthcare information. San Jose, CA, September 10, 2024: OptraHEALTH®, a leading data-driven … WebJan 3, 2011 · OptraHealth, Inc. has sued Invitae Corporation in the Northern District of California, alleging that Invitae’s automated personal assistant for discussing genetic testing results, the Gia Chatbot, infringes U.S. Patent No. 10754882 (entitled “Method of retrieving information from a health report through a machine assisted interrogation process”).
WebFeb 22, 2024 · WASHINGTON (GenomeWeb) – This week, Optra Health, maker of the iPhronesis artificial intelligence platform for automated review of genetics literature and data, stepped into the consumer realm by introducing OptraGuru, an AI-based clinical report interpretation and guidance system. WebGenomeweb — OptraHealth Sues Invitae for Infringement of AI-Based Chatbot Patent News • Sep 10, 2024 Modern Healthcare — OptumHealth launches virtual LGBTQ education program for providers
WebMay 20, 2024 · OptraHealth, Inc. Defendant: Invitae Corporation: Case Number: 4:2024cv03002: Filed: May 20, 2024: Court: US District Court for the Northern District of …
WebAug 10, 2013 · OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice. Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. biobizz light-mixdafiti global fashion groupWebFeb 7, 2024 · OptraHealth, Inc. 4:2024cv00784 US District Court for the Northern District of California Justia Invitae Corporation v. OptraHealth, Inc. RSS Track this Docket Docket … da fit health watchWebBryan Cave Leighton Paisner filed a patent lawsuit Monday in California Northern District Court on behalf of genetic testing company Invitae Corp. over its Genetic Information … dafiti black friday colombiaThe patent is for artificial intelligence technology that automates clinical workflows to return test results and assist physicians in making "real-time, data-driven rich choices that lead to generating better patient experiences and improved health outcomes," according to the court filing. bio blackhead removerWebOptraHEALTH Inc. Overview Plans Ratings + reviews GeneFAX™ Pro : World’s first conversational AI platform with BOT interfaces. GeneFAX™ Pro ChatBOT is a conversational chatbot that seamlessly gathers information from consumers to identify if a genetic test might be beneficial to them such as the Hereditary Cancer Test. da fit instruction manualWebParties, patents and docket of Optrahealth Inc. v. Invitae Corp. (4:22-cv-03002) from Northern District of California filed on 05/20/2024 and closed on 08/09/2024 4:22-cv … biobizz root juice feeding chart